CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3129-3137

  Zaiman, Ari L ^a   Nieves, Angel ^a   Lenz, Jack ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CORE BINDING FACTOR; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; RETROVIRUS; T CELL LYMPHOMA; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS PATHOGENESIS;

EID: 0031901557     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3129-3137.1998     Document Type: Article

References (55)

1. Bae, S. C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809-814.
2. Bhat, N. K., K. L. Komschlies, S. Fujiwara, R. J. Fisher, B. J. Mathieson, T. A. Gregorio, H. A. Young, J. W. Kasik, K. Ozato, and T. S. Papas. 1989. Expression of ets genes in mouse thymocyte subsets and T cells. J. Immunol. 142:672-678.
3. Boral, A. L., S. A. Okenquist, and J. Lenz. 1989. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J. Virol. 63: 76-84.
4. Bradshaw, M. S., S. Y. Tsai, X. Leng, A. D. W. Dobson, O. M. Conneely, B. W. O'Malley, and M. Tsai. 1991. Studies on the mechanism of functional cooperativity between progesterone and estrogen receptors. J. Biol. Chem. 266:16684-16690.
5. Brightman, B. K., A. Rein, D. J. Trepp, and H. Fan. 1991. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate mink cell focus-inducing virus in vivo. Proc. Natl. Acad. Sci. USA 88:2264-2268.
6. Bruhn, L., A. Munnerlyn, and R. Grosschedl. 1997. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRα enhancer function. Genes Dev. 11:640-653.
7. Celander, D., and W. A. Haseltine. 1987. Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region. J. Virol. 61:269-275.
8. Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Frederickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:248-254.
9. Chi, T., P. Lieberman, K. Ellwood, and M. Carey. 1995. A general mechanism for transcriptional synergy by eukaryotic activators. Nature 377:254-257.
10. Corneliussen, B., A. Thornell, B. Hallberg, and T. Grundström. 1991. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65:6084-6093.
11. Dai, H. Y., M. Etzerodt, A. J. Baekgaard, S. Lovmand, P. Jorgensen, N. O. Kjeldgaard, and F. S. Pedersen. 1990. Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression. Virology 175:581-585.
12. DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945-952.
13. DesGroseillers, L., E. Rassart, and P. Jolicoeur. 1983. Thymotropism of murine leukemia virus is conferred by its long terminal repeat. Proc. Natl. Acad. Sci. USA 80:4203-4207.
14. Dudek, H., R. V. Tantravahi, V. N. Rao, S. P. Reddy, and E. P. Reddy. 1992. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc. Natl. Acad. Sci. USA 89:1291-1295.
15. Ethelberg, S., B. Hallberg, J. Lovmand, J. Schmidt, A. Luz, T. Grundström, and F. S. Pedersen. 1997. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus, negative effect of nuclear factor 1 binding site. J. Virol. 71:1196-1206.
16. Evans, L. H., and J. D. Morrey. 1987. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice. J. Virol. 61:1350-1357.
17. Friedman, A. D. 1996. Regulation of immature myeloid cell differentiation by PEBP2/CBF, Myb, C/EBP and Ets family members. Curr. Top. Microbiol. Immunol. 211:149-157.
18. Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995-1008.
19. Golemis, E. A., N. A. Speck, and N. Hopkins. 1990. Alignment of U3 sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:534-542.
20. Gunther, C. V., and B. J. Graves. 1994. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 14:7569-7580.
21. Hallberg, B., J. Schmidt, A. Luz, F. S. Pedersen, and T. Grundström. 1991. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J. Virol. 65:4177-4181.
22. Hernandez-Munain, C., and M. S. Krangel. 1994. Regulation of the T-cell receptor δ enhancer by functional cooperation between c-Myb and core-binding factors. Mol. Cell. Biol. 14:473-483.
23. Hernandez-Munain, C., and M. S. Krangel. 1995. c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor δ enhancer. Mol. Cell. Biol. 15:3090-3099.
24. Hsiang, Y. H., D. Spencer, S. Wang, N. A. Speck, and D. H. Raulet. 1993. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-γ and -δ gene expression. J. Immunol. 150:3905-3916.
25. Ishimoto, A., M. Takimoto, A. Adachi, M. Kakuyama, S. Kato, K. Kakimi, K. Fukuoka, T. Ogiu, and M. Matsuyama. 1987. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses. J. Virol. 61: 1861-1866.
26. Kamachi, Y., E. Ogawa, M. Asano, S. Ishida, Y. Murakami, M. Satake, Y. Ito, and K. Shigesada. 1990. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J. Virol. 64: 4808-4819.
27. Khoury, G., and P. Gruss. 1983. Enhancer elements. Cell 33:313-314.
28. Lenz, J., D. Celander, R. L. Crowther, R. Patarca, D. W. Perkins, and W. A. Haseltine. 1984. Determination of the leukemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 308:467-470.
29. Li, Y., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:693-700.
30. LoSardo, J., A. Nieves, and J. Lenz. Unpublished data.
31. LoSardo, J. E., A. L. Boral, and J. Lenz. 1990. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity. J. Virol. 64: 1756-1763.
32. Morrison, H. L., B. Soni, and J. Lenz. 1995. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:446-455.
33. Nielsen, A. L., P. L. Norby, F. S. Pedersen, and P. Jorgensen. 1996. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J. Biol. Chem. 271:31463-31469.
34. Nielsen, A. L., P. L. Nørby, F. S. Pedersen, and P. Jørgensen. 1996. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines. J. Virol. 70:5893-5901.
35. Nielsen, A. L., N. Pallisgaard, F. S. Pedersen, and P. Jørgensen. 1994. Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J. Virol. 68:5638-5647.
36. Nieves, A., L. S. Levy, and J. Lenz. 1997. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3. J. Virol. 71:1213-1219.
37. Nuchprayoon, I., S. Meyers, L. M. Scott, J. Suzow, S. Hiebert, and A. D. Friedman. 1994. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell. Biol. 14:5558-5568.
38. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90:6859-6863.
39. Pantginis, J., R. M. Beaty, L. S. Levy, and J. Lenz. 1997. The Feline leukemia virus long terminal repeat contains a potent determinant of T-cell lymphomagenicity. J. Virol. 71:9786-9791.
40. Pedersen, F. S., R. L. Crowther, D. L. Tenney, A. M. Reimhold, and W. A. Haseltine. 1981. Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature 292:167-170.
41. Rosen, C. A., W. A. Haseltine, J. Lenz, R. Ruprecht, and M. W. Cloyd. 1985. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55:862-866.
42. Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1101-1110.
43. Speck, N. A., B. Renjifo, E. Golemis, T. Fredrickson, J. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233-242.
44. Speck, N. A., B. Renjifo, and N. Hopkins. 1990. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J. Virol. 64: 543-550.
45. Sun, W., B. J. Graves, and N. A. Speck. 1995. Transactivation of the Moloney murine leukemia virus and T-cell receptor β-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69:4941-4949.
46. Sun, W., M. O'Connell, and N. A. Speck. 1993. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers. J. Virol. 67:1976-1986.
47. Thompson, C. B., C.-Y. Wang, I. Ho, P. R. Bohjanen, B. Petryniak, C. H. June, S. Miesfeldt, L. Zhang, G. J. Nabel, B. Karpinski, and J. M. Leiden. 1992. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol. Cell. Biol. 12:1043-1053.
48. Thornell, A., B. Hallberg, and T. Grundström. 1988. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. Mol. Cell. Biol. 8:1625-1637.
49. Thornell, A., B. Hallberg, and T. Grundström. 1991. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences. J. Virol. 65:42-50.
50. Tsai, S. Y., M. Tsai, and B. W. O'Malley. 1989. Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at the target enhancer elements. Cell 57:443-448.
51. Vogt, M., C. Haggblom, S. Swift, and M. Haas. 1985. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses. J. Virol. 55:184-192.
52. Wang, S., and N. A. Speck. 1992. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12:89-102.
53. Weiher, H., M. König, and P. Gruss. 1983. Multiple point mutations affecting the simian virus 40 enhancer. Science 219:626-631.
54. Zaiman, A. L., and J. Lenz. 1996. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb. J. Virol. 70:5618-5629.
55. Zaiman, A. L., A. F. Lewis, B. E. Crute, N. A. Speck, and J. Lenz. 1995. Transcriptional activity of core binding factor a (AML1) and β subunits on murine leukemia virus enhancer cores. J. Virol. 69:2898-2906.